Business ❯Pharmaceuticals ❯Drug Development ❯Clinical Trials

Weight Loss Drugs

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short